Site icon Technology and Fitness

The proteogenomic landscape of the human kidney and implications for cardio-kidney-metabolic health

The proteogenomic landscape of the human kidney and implications for cardio-kidney-metabolic health
  • Ndumele, C. E. et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation 148, 1606–1635 (2023).

    PubMed 

    Google Scholar 

  • Sullivan, K. M. & Susztak, K. Unravelling the complex genetics of common kidney diseases: from variants to mechanisms. Nat. Rev. Nephrol. 16, 628–640 (2020).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Liu, H. et al. Epigenomic and transcriptomic analyses define core cell types, genes and targetable mechanisms for kidney disease. Nat. Genet. 54, 950–962 (2022).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Sheng, X. et al. Mapping the genetic architecture of human traits to cell types in the kidney identifies mechanisms of disease and potential treatments. Nat. Genet. 53, 1322–1333 (2021).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Qiu, C. et al. Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease. Nat. Med. 24, 1721–1731 (2018).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Ko, Y. A. et al. Genetic-variation-driven gene-expression changes highlight genes with important functions for kidney disease. Am. J. Hum. Genet. 100, 940–953 (2017).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Eales, J. M. et al. Uncovering genetic mechanisms of hypertension through multi-omic analysis of the kidney. Nat. Genet. 53, 630–637 (2021).

    CAS 
    PubMed 

    Google Scholar 

  • GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318–1330 (2020).

  • Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329–338 (2023).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Zhang, J. et al. Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies. Nat. Genet. 54, 593–602 (2022).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Ferkingstad, E. et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet. 53, 1712–1721 (2021).

    CAS 
    PubMed 

    Google Scholar 

  • Xu, X. et al. Genetic imputation of kidney transcriptome, proteome and multi-omics illuminates new blood pressure and hypertension targets. Nat. Commun. 15, 2359 (2024).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Ritchie, S. C. et al. Integrative analysis of the plasma proteome and polygenic risk of cardiometabolic diseases. Nat. Metab. 3, 1476–1483 (2021).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Inker, L. A. et al. New creatinine- and cystatin C–based equations to estimate GFR without race. N. Engl. J. Med. 385, 1737–1749 (2021).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Sun, B. B. et al. Genomic atlas of the human plasma proteome. Nature 558, 73–79 (2018).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • McLaren, W. et al. The Ensembl Variant Effect Predictor. Genome Biol. 17, 122 (2016).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Enroth, S., Hallmans, G., Grankvist, K. & Gyllensten, U. Effects of long-term storage time and original sampling month on biobank plasma protein concentrations. EBioMedicine 12, 309–314 (2016).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Chesnaye, N. C., Carrero, J. J., Hecking, M. & Jager, K. J. Differences in the epidemiology, management and outcomes of kidney disease in men and women. Nat. Rev. Nephrol. 20, 7–20 (2024).

    PubMed 

    Google Scholar 

  • Dhindsa, R. S. et al. Rare variant associations with plasma protein levels in the UK Biobank. Nature 622, 339–347 (2023).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Shao, X. et al. CellTalkDB: a manually curated database of ligand–receptor interactions in humans and mice. Brief. Bioinform. 22, bbaa269 (2021).

  • Eldjarn, G. H. et al. Large-scale plasma proteomics comparisons through genetics and disease associations. Nature 622, 348–358 (2023).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Hirohama, D. et al. Unbiased human kidney tissue proteomics identifies matrix metalloproteinase 7 as a kidney disease biomarker. J. Am. Soc. Nephrol. 34, 1279–1291 (2023).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Battle, A. et al. Genomic variation. Impact of regulatory variation from RNA to protein. Science 347, 664–667 (2015).

    CAS 
    PubMed 

    Google Scholar 

  • Assum, I. et al. Tissue-specific multi-omics analysis of atrial fibrillation. Nat. Commun. 13, 441 (2022).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • He, B., Shi, J., Wang, X., Jiang, H. & Zhu, H. J. Genome-wide pQTL analysis of protein expression regulatory networks in the human liver. BMC Biol. 18, 97 (2020).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Pietzner, M. et al. Synergistic insights into human health from aptamer- and antibody-based proteomic profiling. Nat. Commun. 12, 6822 (2021).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Visscher, P. M. et al. 10 years of GWAS discovery: biology, function, and translation. Am. J. Hum. Genet. 101, 5–22 (2017).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Liu, H. et al. Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants. Science 387, eadp4753 (2025).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Giambartolomei, C. et al. A Bayesian framework for multiple trait colocalization from summary association statistics. Bioinformatics 34, 2538–2545 (2018).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Guan, Y. et al. A single genetic locus controls both expression of DPEP1/CHMP1A and kidney disease development via ferroptosis. Nat. Commun. 12, 5078 (2021).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Ku, E., Lee, B. J., Wei, J. & Weir, M. R. Hypertension in CKD: Core Curriculum 2019. Am. J. Kidney Dis. 74, 120–131 (2019).

    PubMed 

    Google Scholar 

  • Klag, M. J. et al. Blood pressure and end-stage renal disease in men. N. Engl. J. Med. 334, 13–18 (1996).

    CAS 
    PubMed 

    Google Scholar 

  • Jafar, T. H. et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann. Intern. Med. 139, 244–252 (2003).

    CAS 
    PubMed 

    Google Scholar 

  • Zhu, Z. et al. Causal associations between risk factors and common diseases inferred from GWAS summary data. Nat. Commun. 9, 224 (2018).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Raal, F. J. et al. Evinacumab for homozygous familial hypercholesterolemia. N. Engl. J. Med. 383, 711–720 (2020).

    CAS 
    PubMed 

    Google Scholar 

  • Shimizugawa, T. et al. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J. Biol. Chem. 277, 33742–33748 (2002).

    CAS 
    PubMed 

    Google Scholar 

  • Freshour, S. L. et al. Integration of the Drug–Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res. 49, D1144–D1151 (2021).

    CAS 
    PubMed 

    Google Scholar 

  • Raies, A. et al. DrugnomeAI is an ensemble machine-learning framework for predicting druggability of candidate drug targets. Commun. Biol. 5, 1291 (2022).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Xie, J. et al. The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis. Nat. Commun. 11, 1600 (2020).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Pietzner, M. et al. Mapping the proteo-genomic convergence of human diseases. Science 374, eabj1541 (2021).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Hoxha, E., Reinhard, L. & Stahl, R. A. K. Membranous nephropathy: new pathogenic mechanisms and their clinical implications. Nat. Rev. Nephrol. 18, 466–478 (2022).

    CAS 
    PubMed 

    Google Scholar 

  • Coenen, M. J. et al. Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy. J. Am. Soc. Nephrol. 24, 677–683 (2013).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Hoxha, E. et al. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int. 82, 797–804 (2012).

    CAS 
    PubMed 

    Google Scholar 

  • Sukocheva, O. et al. Current insights into functions of phospholipase A2 receptor in normal and cancer cells: more questions than answers. Semin. Cancer Biol. 56, 116–127 (2019).

    CAS 
    PubMed 

    Google Scholar 

  • Griveau, A. et al. Targeting the phospholipase A2 receptor ameliorates premature aging phenotypes. Aging Cell 17, e12835 (2018).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Yang, B., Shen, F., Zhu, Y. & Cai, H. Downregulating ANGPTL3 by miR-144-3p promoted TGF-β1-induced renal interstitial fibrosis via activating PI3K/AKT signaling pathway. Heliyon 10, e24204 (2024).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Ma, Y. et al. Podocyte protection by Angptl3 knockout via inhibiting ROS/GRP78 pathway in LPS-induced acute kidney injury. Int. Immunopharmacol. 105, 108549 (2022).

    CAS 
    PubMed 

    Google Scholar 

  • Sarwar, N. et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 379, 1205–1213 (2012).

    PubMed 

    Google Scholar 

  • Swerdlow, D. I. et al. The interleukin-6 receptor as a target for prevention of coronary heart disease: a Mendelian randomisation analysis. Lancet 379, 1214–1224 (2012).

    PubMed 

    Google Scholar 

  • Du, X. Y. et al. The potential mechanism of INHBC and CSF1R in diabetic nephropathy. Eur. Rev. Med. Pharm. Sci. 24, 1970–1978 (2020).

    Google Scholar 

  • Yang, H., Lian, D., Zhang, X., Li, H. & Xin, G. Key genes and signaling pathways contribute to the pathogensis of diabetic nephropathy. Iran. J. Kidney Dis. 13, 87–97 (2019).

    PubMed 

    Google Scholar 

  • Schlosser, P. et al. Transcriptome- and proteome-wide association studies nominate determinants of kidney function and damage. Genome Biol. 24, 150 (2023).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Graham, S. E. et al. The power of genetic diversity in genome-wide association studies of lipids. Nature 600, 675–679 (2021).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Gold, L. et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE 5, e15004 (2010).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Niewczas, M. A. et al. A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes. Nat. Med. 25, 805–813 (2019).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Li, G. X. et al. Comprehensive proteogenomic characterization of rare kidney tumors. Cell Rep. Med. 5, 101547 (2024).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Assarsson, E. et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE 9, e95192 (2014).

    PubMed 
    PubMed Central 

    Google Scholar 

  • O’Brien, J. J. et al. A data analysis framework for combining multiple batches increases the power of isobaric proteomics experiments. Nat. Methods 21, 290–300 (2024).

    PubMed 

    Google Scholar 

  • Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25, 1754–1760 (2009).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Picard Tools. Broad Institute. (2018).

  • McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303 (2010).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Sherry, S. T. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308–311 (2001).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Abecasis, G. R. et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56–65 (2012).

    PubMed 

    Google Scholar 

  • International HapMap Consortium. The International HapMap Project. Nature 426, 789–796 (2003).

  • Auton, A. et al. A global reference for human genetic variation. Nature 526, 68–74 (2015).

    PubMed 

    Google Scholar 

  • Mills, R. E. et al. An initial map of insertion and deletion (INDEL) variation in the human genome. Genome Res. 16, 1182–1190 (2006).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Price, A. L. et al. Long-range LD can confound genome scans in admixed populations. Am. J. Hum. Genet. 83, 132–135; author reply 135–139 (2008).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Delaneau, O. et al. A complete tool set for molecular QTL discovery and analysis. Nat. Commun. 8, 15452 (2017).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Stegle, O., Parts, L., Piipari, M., Winn, J. & Durbin, R. Using probabilistic estimation of expression residuals (PEER) to obtain increased power and interpretability of gene expression analyses. Nat. Protoc. 7, 500–507 (2012).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Storey, J. D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl Acad. Sci. USA 100, 9440–9445 (2003).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Yang, J. et al. Common SNPs explain a large proportion of the heritability for human height. Nat. Genet. 42, 565–569 (2010).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Wingo, A. P. et al. Sex differences in brain protein expression and disease. Nat. Med. 29, 2224–2232 (2023).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Lee, S., Wu, M. C. & Lin, X. Optimal tests for rare variant effects in sequencing association studies. Biostatistics 13, 762–775 (2012).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff. Fly (Austin) 6, 80–92 (2012).

    CAS 
    PubMed 

    Google Scholar 

  • Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, 369–375, S1–3 (2012).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Xu, F. et al. Genome-wide genotype-serum proteome mapping provides insights into the cross-ancestry differences in cardiometabolic disease susceptibility. Nat. Commun. 14, 896 (2023).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Sherman, B. T. et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50, W216–W221 (2022).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Evangelou, E. et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat. Genet. 50, 1412–1425 (2018).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Wallace, C. A more accurate method for colocalisation analysis allowing for multiple causal variants. PLoS Genet. 17, e1009440 (2021).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Wang, C. et al. Genetic architecture of cerebrospinal fluid and brain metabolite levels and the genetic colocalization of metabolites with human traits. Nat. Genet. 56, 2685–2695 (2024).

    CAS 
    PubMed 

    Google Scholar 

  • Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481–487 (2016).

    CAS 
    PubMed 

    Google Scholar 

  • Wu, Y. et al. Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits. Nat. Commun. 9, 918 (2018).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Burgess, S., Davies, N. M. & Thompson, S. G. Bias due to participant overlap in two-sample Mendelian randomization. Genet. Epidemiol. 40, 597–608 (2016).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Xue, A. et al. Unravelling the complex causal effects of substance use behaviours on common diseases. Commun. Med. (Lond.) 4, 43 (2024).

    PubMed 

    Google Scholar 

  • Karczewski, K. J. et al. Pan-UK Biobank GWAS improves discovery, analysis of genetic architecture, and resolution into ancestry-enriched effects. Preprint at medRxiv (2024).

  • Pulit, S. L. et al. Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. Hum. Mol. Genet. 28, 166–174 (2019).

    CAS 
    PubMed 

    Google Scholar 

  • Vujkovic, M. et al. A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation. Nat. Genet. 54, 761–771 (2022).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Haas, M. E. et al. Machine learning enables new insights into genetic contributions to liver fat accumulation. Cell Genom. 1, 100066 (2021).

  • Suzuki, K. et al. Genetic drivers of heterogeneity in type 2 diabetes pathophysiology. Nature 627, 347–357 (2024).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Chen, J. et al. The trans-ancestral genomic architecture of glycemic traits. Nat. Genet. 53, 840–860 (2021).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Wuttke, M. et al. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat. Genet. 51, 957–972 (2019).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Aragam, K. G. et al. Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants. Nat. Genet. 54, 1803–1815 (2022).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Levin, M. G. et al. Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure. Nat. Commun. 13, 6914 (2022).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Mishra, A. et al. Stroke genetics informs drug discovery and risk prediction across ancestries. Nature 611, 115–123 (2022).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Hartiala, J. A. et al. Genome-wide analysis identifies novel susceptibility loci for myocardial infarction. Eur. Heart J. 42, 919–933 (2021).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • van Zuydam, N. R. et al. Genome-wide association study of peripheral artery disease. Circ. Genom. Precis. Med. 14, e002862 (2021).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Pirruccello, J. P. et al. Analysis of cardiac magnetic resonance imaging in 36,000 individuals yields genetic insights into dilated cardiomyopathy. Nat. Commun. 11, 2254 (2020).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Nauffal, V. et al. Genetics of myocardial interstitial fibrosis in the human heart and association with disease. Nat. Genet. 55, 777–786 (2023).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Sakaue, S. et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat. Genet. 53, 1415–1424 (2021).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Han, S. K. et al. Mapping genomic regulation of kidney disease and traits through high-resolution and interpretable eQTLs. Nat. Commun. 14, 2229 (2023).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Hemani, G., Tilling, K. & Davey Smith, G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 13, e1007081 (2017).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Foley, C. N. et al. A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits. Nat. Commun. 12, 764 (2021).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Gill, D. et al. Common pitfalls in drug target Mendelian randomization and how to avoid them. BMC Med. 22, 473 (2024).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Zuber, V. et al. Combining evidence from Mendelian randomization and colocalization: review and comparison of approaches. Am. J. Hum. Genet. 109, 767–782 (2022).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Koplev, S. et al. A mechanistic framework for cardiometabolic and coronary artery diseases. Nat. Cardiovasc. Res. 1, 85–100 (2022).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Brotman, S. M. et al. Adipose tissue eQTL meta-analysis highlights the contribution of allelic heterogeneity to gene expression regulation and cardiometabolic traits. Nat. Genet. 57, 180–192 (2025).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • de Klein, N. et al. Brain expression quantitative trait locus and network analyses reveal downstream effects and putative drivers for brain-related diseases. Nat. Genet. 55, 377–388 (2023).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Abedini, A. et al. Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression. Nat. Genet. 56, 1712–1724 (2024).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Sriworarat, C. et al. Performant web-based interactive visualization tool for spatially-resolved transcriptomics experiments. Biol. Imaging 3, e15 (2023).

    PubMed 
    PubMed Central 

    Google Scholar 

  • link

    Exit mobile version